← FDA DRUG APPROVALS

FDA NDA · NDA009410

LOTUSATE

Sponsor: SANOFI AVENTIS US

APPLICATION
NDA009410
TYPE
NDA
ORIGINAL APPROVAL
1954-09-21
LATEST ACTION
1998-05-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

LOTUSATEDiscontinued
TALBUTAL 120MG · TABLET · ORAL

Approval history

1998-05-12Labeling · Supplement 5AP
1998-05-12Labeling · Supplement 3AP
1985-10-29Labeling · Supplement 8AP
1982-03-15Labeling · Supplement 7AP
1980-04-02Labeling · Supplement 6AP
1954-09-21Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →